ATP P2 receptors and regulation of bone effector cells

Journal of Musculoskeletal Neuronal Interactions

Volumn 4, Issue 2, 2004, Pages 125-127

  Gallagher, Jim A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Bone; Bone remodeling; Extracellular ATP; Extracellular nucleotides; Osteoblasts; Osteoclasts; P2 receptors; RANKL; Ultrasound

Indexed keywords

ADENOSINE TRIPHOSPHATE; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; LIGAND; NUCLEOTIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE RECEPTOR; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; REGULATOR PROTEIN;

BONE CELL; CELL MEMBRANE; CHANNEL GATING; EFFECTOR CELL; EXTRACELLULAR SPACE; GENE INTERACTION; HUMAN; MEMBRANE FUSION; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; POROSITY; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ADENOSINE TRIPHOSPHATE; ANIMALS; BONE AND BONES; BONE REMODELING; HUMANS; RECEPTORS, PURINERGIC P2;

EID: 3042856490     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Gallagher JA, Buckley KA. Expression and function of P2 receptors in bone. J Musculoskel Nueron Interact 2002; 2:432-439.
2. Hoebertz A, Arnett TR, Burnstock G. Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 2003; 24:290-297.
3. Bowler WB, Buckley KA, Gartland A, Hipskind RA, Bilbe G, Gallagher JA. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone 2001; 28:507-512.
4. Dixon SJ, Sims SM. P2 Purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Dev Res 2000; 49:187-200.
5. Drury AN, Szent-Györgyi AY. The physiological activity of adenosine compounds with a special reference to their action upon the mammalian heart. J Physiol (Lond) 1929; 68:213-237.
6. Burnstock G. Purinergic nerves. Pharmacol Rev 1972; 24:509-581.
7. Schöfl C, Cuthbertson KS, Walsh CA, Mayne C, Cobbold P, von zur Mühlen A, Hesch RD, Gallagher JA. Evidence for P2-purinoceptors on human osteoblast-like cells. J Bone Miner Res 1992; 7:485-491.
8. Kumagai H, Sacktor B, Filburn CR. Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells. J Bone Miner Res 1991; 6:697-708.
9. 2U purinoceptor present in osteoclastoma, bone and osteoblasts. J Bone Miner Res 1995; 10:1137-1145.
10. Bowler WB, Littlewood-Evans A, Bilbe G, Gallagher JA, Dixon CJ. P2Y2 receptors are expressed by human osteoclasts of giant cell tumour but do not mediate ATP-induced bone resorption. Bone 1998; 22:195-200.
11. i in rat osteoblastic cells by interaction with two receptor subtypes. Am J Physiol 1992; 263:C1040-C1048.
12. Morrison MS, Turin L, King BF, Burnstock G, Arnett TR. ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol 1998; 511:495-500.
13. Yu H, Ferrier J. Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors. FEBS Lett 1993; 328:209-214.
14. 7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 2001; 16:846-856.
15. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR. Expression of P2 receptors in bone and cultured bone cells. Bone 2000; 27:503-510.
16. 2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J Biol Chem 1999; 274:14315-14324.
17. i release in rat osteoblasts independently of Gq activation or cyclic monophosphate accumulation: a mechanism for localizing systemic responses in bone. J Biol Chem 2001; 276:9565-9571.
18. Buckley KA, Hipskind RA, Gartland A, Bowler WB, Gallagher JA. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. Bone 2002; 31:582-590.
19. Gartland A, Buckley KA, Bowler WB, Gallagher JA. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 2003; 73:361-369.
20. Gartland A, Buckley KA, Hipskind RA, Perry MJ, Tobias JH, Buell G, Chessell I, Bowler WB, Gallagher JA. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Crit Rev Eukaryot Gene Expr 2003; 13:243-253.
21. Gartland A, Buckley KA, Hipskind RA, Bowler WB, Gallagher JA. P2 receptors in bone-modulation of osteoclast formation and activity via P2X7 activation. Crit Rev Eukaryot Gene Expr 2003; 13:237-242.
22. Buckley KA, Golding SL, Rice JM, Dillon JP, Gallagher JA. Release and interconversion of P2 receptor agonists by human osteoblast-like cells. FASEB J 2003; 17:1401-1410.
23. Hayton MJ, Dillon JP, Glynn D, Curran JM, Hunt JA, Gallagher JA, Buckley KA. Ultrasound stimulation induces adenosine 5′-triphosphate release and promotes osteogenic gene expression by human osteoblasts in vitro. (Submitted).